Healthcare - Sector
Tcr2 Therapeutics's activity chart (see below) currently has 52 price targets and 46 ratings on display.
Analysts' price targets on this stock were met 21.71% of the time, taking 88.59 days on average.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 12-May-2023. First documented stock forecast 11-Mar-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-May-2023
$2.11
$1.72
3 years 6 months 9 days ago
(12-May-2023)
2/7 (28.57%)
$0.15 (7.65%)
86
Hold Since 31-May-2019
$2
$2
3 years 7 months 29 days ago
(23-Mar-2023)
1/3 (33.33%)
$0.58 (40.85%)
4
Buy Since 21-Sep-2021
$3
3 years 8 months 13 days ago
(08-Mar-2023)
0/2 (0%)
$1.4 (87.50%)
Buy Since 14-Dec-2020
3 years 8 months 14 days ago
(07-Mar-2023)
0/3 (0%)
$15.09 (385.93%)
Buy Since 11-Mar-2019
$26
3 years 10 months 15 days ago
(06-Jan-2023)
0/5 (0%)
$19.92 (327.63%)
What is TCRR (Tcr2 Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on TCRR (Tcr2 Therapeutics)?
Which analyst has the most public recommendations on TCRR (Tcr2 Therapeutics)?
Which analyst is the currently most bullish on TCRR (Tcr2 Therapeutics)?
Which analyst is the currently most reserved on TCRR (Tcr2 Therapeutics)?